Abstract

Heterotrimeric G proteins signal at a variety of endomembrane locations, in addition to their canonical function at the cytoplasmic surface of the plasma membrane (PM), where they are activated by cell surface G protein-coupled receptors. Here we focus on βγ signaling at the Golgi, where βγ activates a signaling cascade, ultimately resulting in vesicle fission from the trans-Golgi network (TGN). To develop a novel molecular tool for inhibiting endogenous βγ in a spatial-temporal manner, we take advantage of a lipid association mutant of the widely used βγ inhibitor GRK2ct (GRK2ct-KERE) and the FRB/FKBP heterodimerization system. We show that GRK2ct-KERE cannot inhibit βγ function when expressed in cells, but recruitment to a specific membrane location recovers the ability of GRK2ct-KERE to inhibit βγ signaling. PM-recruited GRK2ct-KERE inhibits lysophosphatidic acid-induced phosphorylation of Akt, whereas Golgi-recruited GRK2ct-KERE inhibits cargo transport from the TGN to the PM. Moreover, we show that Golgi-recruited GRK2ct-KERE inhibits model basolaterally targeted but not apically targeted cargo delivery, for both PM-destined and secretory cargo, providing the first evidence of selectivity in terms of cargo transport regulated by βγ. Last, we show that Golgi fragmentation induced by ilimaquinone and nocodazole is blocked by βγ inhibition, demonstrating that βγ is a key regulator of multiple pathways that impact Golgi morphology. Thus, we have developed a new molecular tool, recruitable GRK2ct-KERE, to modulate βγ signaling at specific subcellular locations, and we demonstrate novel cargo selectivity for βγ regulation of TGN to PM transport and a novel role for βγ in mediating Golgi fragmentation.

Highlights

  • Heterotrimeric G proteins are molecular switches that activate global downstream signaling cascades within the cell

  • A Lipid-binding Region of GRK2 C Terminus Is Necessary for Inhibition of Endogenous ␤␥ Signaling at the Golgi—To be able to differentiate between subcellular pools of ␤␥ responsible for differential signaling pathways, we set out to develop a version of GRK2ct that could inhibit ␤␥ only when targeted to a specific membrane location

  • We report the development of a novel molecular tool for spatial and temporal inhibition of endogenous ␤␥, and we have used this tool to expand our knowledge of the role of ␤␥ in regulating Golgi to plasma membrane (PM) transport and Golgi morphology

Read more

Summary

Results

A Lipid-binding Region of GRK2 C Terminus Is Necessary for Inhibition of Endogenous ␤␥ Signaling at the Golgi—To be able to differentiate between subcellular pools of ␤␥ responsible for differential signaling pathways, we set out to develop a version of GRK2ct that could inhibit ␤␥ only when targeted to a specific membrane location. Statistical significance compared with the first bar (BL-VSV-G-YFP ϩ FRB-GRK2ct-KERE ϩ Golgi-FKBP-CFP without rapamycin) was tested using an unpaired t test (****, p Ͻ 0.0001; NS, no significant difference). Of cells display diffuse fragmented Golgi (Fig. 8, A and B (third row) and C) Both PM-recruited and Golgirecruited FRB-GRK2ct-KERE block this fragmentation, as observed by ilimaquinone-induced Golgi fragmentation in only 40 and 20% of cells, respectively. Upon treatment with nocodazole but in the absence of rapamycin, Ͼ80% of cells expressing the inducible system components display a fragmented Golgi (Fig. 9, A and B, third row). FRB-GRK2ct-KERE is recruited to the Golgi (upon rapamycin addition), only 44% of cells display a fragmented Golgi phenotype (Fig. 9A, bottom row). There is a striking difference in the subcellular pools of G␤␥ regulating ilimaquinone- versus nocodazole-induced Golgi fragmentation

Discussion
Experimental Procedures
Cargo Transport Assays
Golgi Fragmentation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.